Filana Therapeutics (FLNA) Other financing activities (2010 - 2025)

Filana Therapeutics has reported Other financing activities for 10 years, with the latest figure at $90000.0 in Q1 2025.

• On a quarterly basis, Other financing activities fell 99.59% year-over-year to $90000.0 in Q1 2025; TTM through Dec 2025 was $90000.0, a 99.93% decrease from a year earlier, with the FY2025 full-year figure at $90000.0, down 99.93% from the prior year.
• Other financing activities was $90000.0 for Q1 2025 at Filana Therapeutics, down from $101.4 million in the prior quarter.
• The five-year high for Other financing activities was $101.4 million in Q2 2024, with the low at $9000.0 in Q4 2022.
• Average Other financing activities over 5 years is $12.7 million, with a median of $578000.0 recorded in 2021.
• The sharpest annual moves came in 2024 and 2025: Other financing activities jumped 34525.0% in 2024, then slumped 99.59% in 2025.
• Over 5 years, Other financing activities stood at $692000.0 in 2021, then tumbled by 98.7% to $9000.0 in 2022, then surged by 12600.0% to $1.1 million in 2023, then soared by 8770.69% to $101.4 million in 2024, then plunged by 99.91% to $90000.0 in 2025.
• The last three Other financing activities figures came in at $90000.0 (Q1 2025), $101.4 million (Q2 2024), and $22.2 million (Q1 2024), per Business Quant data.